Arkadios Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $958K | Buy |
2,152
+697
| +48% | +$310K | 0.03% | 582 |
|
|
2025
Q1 | $706K | Buy |
1,455
+374
| +35% | +$181K | 0.03% | 581 |
|
|
2024
Q4 | $435K | Buy |
1,081
+410
| +61% | +$165K | 0.02% | 601 |
|
|
2024
Q3 | $312K | Buy |
+671
| New | +$312K | 0.02% | 693 |
|
|
2021
Q4 | – | Sell |
-121
| Closed | -$21K | – | 1750 |
|
|
2021
Q3 | $21K | Buy |
121
+21
| +21% | +$3.65K | ﹤0.01% | 1202 |
|
|
2021
Q2 | $20K | Buy |
+100
| New | +$20K | ﹤0.01% | 1299 |
|
|
2020
Q2 | – | Sell |
-4
| Closed | -$952 | – | 1156 |
|
|
2020
Q1 | $952 | Buy |
+4
| New | +$952 | ﹤0.01% | 971 |
|